Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 123
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Epilepsia ; 65(2): 430-444, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-37872396

RESUMO

OBJECTIVE: This study was undertaken to evaluate our treatment algorithm for infantile epileptic spasms syndrome (IESS) used between 2000 and 2018. We initiated vigabatrin (VGB), and steroids were added if the electroclinical response (spasms and electroencephalogram [EEG]) to VGB was not obtained or incomplete. METHODS: Individuals with IESS treated with VGB were recruited from our hospital clinical data warehouse based on electronic health records (EHRs) generated since 2009 and containing relevant keywords. We confirmed the diagnosis of IESS. Clinical, EEG, imaging, and biological data were extracted from the EHRs. We analyzed factors associated with short-term response, time to response, relapse, time to relapse of spasms, and the presence of spasms at last follow-up. RESULTS: We collected data from 198 individuals (female: 46.5%, IESS onset: 6 [4.5-10.3] months, follow-up: 4.6 [2.5-7.6] years, median [Q1-Q3]) including 129 (65.2%) with identifiable etiology. VGB was started 17 (5-57.5) days after IESS diagnosis. A total of 113 individuals were responders (57.1% of the cohort), 64 with VGB alone and 38 with VGB further combined with steroids (56.6% and 33.6% of responders, respectively). Among responders, 33 (29%) experienced relapses of spasms, mostly those with later onset of spasms (p = .002) and those who received VGB for <24 months after spasms cessation compared to a longer duration on VGB (45% vs. 12.8%, p = .003). At follow-up, 92 individuals were seizure-free (46.5% of the whole cohort), including 26 free of therapy (13.1%). One hundred twelve individuals (56.6%) were still receiving VGB, with a duration of 3.2 (1.75-5.7) years. SIGNIFICANCE: Our sequential protocol introducing VGB then adding steroids is an effective alternative to a combined VGB-steroids approach in IESS. It avoids steroid-related adverse events, as well as those from VGB-steroid combination. According to our data, a period of 7 days seems sufficient to assess VGB response and enables the addition of steroids rapidly if needed. Continuing VGB for 2 years may balance the risk of relapse and treatment-induced adverse events.


Assuntos
Espasmos Infantis , Vigabatrina , Humanos , Feminino , Lactente , Anticonvulsivantes/efeitos adversos , Espasmos Infantis/tratamento farmacológico , Espasmos Infantis/diagnóstico , Resultado do Tratamento , Espasmo/tratamento farmacológico , Síndrome , Recidiva , Esteroides/uso terapêutico
2.
Neuropediatrics ; 54(3): 188-196, 2023 06.
Artigo em Inglês | MEDLINE | ID: mdl-36223876

RESUMO

BACKGROUND: Focal cortical dysplasias (FCD) are a frequent cause of drug-resistant epilepsy in children but are often undetected on structural magnetic resonance imaging (MRI). We aimed to measure and validate the variation of resting state functional MRI (rs-fMRI) blood oxygenation level dependent (BOLD) metrics in surgically proven FCDs in children, to assess the potential yield for detecting and understanding these lesions. METHODS: We prospectively included pediatric patients with surgically proven FCD with inconclusive structural MRI and healthy controls, who underwent a ten-minute rs-fMRI acquired at 3T. Rs-fMRI data was pre-processed and maps of values of regional homogeneity (ReHo), degree centrality (DC), amplitude of low frequency fluctuations (ALFF) and fractional ALFF (fALFF) were calculated. The variations of BOLD metrics within the to-be-resected areas were analyzed visually, and quantitatively using lateralization indices. BOLD metrics variations were also analyzed in fluorodeoxyglucose-positron emission tomography (FDG-PET) hypometabolic areas. RESULTS: We included 7 patients (range: 3-15 years) and 6 aged-matched controls (range: 6-17 years). ReHo lateralization indices were positive in the to-be-resected areas in 4/7 patients, and in 6/7 patients in the additional PET hypometabolic areas. These indices were significantly higher compared to controls in 3/7 and 4/7 patients, respectively. Visual analysis revealed a good spatial correlation between high ReHo areas and MRI structural abnormalities (when present) or PET hypometabolic areas. No consistent variation was seen using DC, ALFF, or fALFF. CONCLUSION: Resting-state fMRI metrics, noticeably increase in ReHo, may have potential to help detect MRI-negative FCDs in combination with other morphological and functional techniques, used in clinical practice and epilepsy-surgery screening.


Assuntos
Epilepsia Resistente a Medicamentos , Displasia Cortical Focal , Humanos , Criança , Idoso , Tomografia por Emissão de Pósitrons/métodos , Imageamento por Ressonância Magnética/métodos , Encéfalo/diagnóstico por imagem , Encéfalo/cirurgia , Mapeamento Encefálico/métodos
3.
Dev Med Child Neurol ; 65(12): 1607-1616, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37198755

RESUMO

AIM: To evaluate the safety and efficacy of stiripentol initiated before 2 years of age in patients with Dravet syndrome. METHOD: This was a 30-year, real-world retrospective study. We extracted the data of the 131 patients (59 females, 72 males) who initiated stiripentol before 2 years of age between 1991 and 2021 from the four longitudinal databases of Dravet syndrome available in France. RESULTS: Stiripentol was added to valproate and clobazam (93%) at 13 months and a median dose of 50 mg/kg/day. With short-term therapy (<6 months on stiripentol, median 4 months, median age 16 months), the frequency of tonic-clonic seizures (TCS) lasting longer than 5 minutes decreased (p < 0.01) and status epilepticus (>30 minutes) disappeared in 55% of patients. With long-term therapy (last visit on stiripentol <7 years of age, median stiripentol 28 months, median age 41 months), the frequency of long-lasting TCS continued to decline (p = 0.03). Emergency hospitalizations dropped from 91% to 43% and 12% with short- and long-term therapies respectively (p < 0.001). Three patients died, all from sudden unexpected death in epilepsy. Three patients discontinued stiripentol for adverse events; 55% reported at least one adverse event, mostly loss of appetite/weight (21%) and somnolence (11%). Stiripentol was used earlier, at lower doses, and was better tolerated by patients in the newest database than in the oldest (p < 0.01). INTERPRETATION: Initiating stiripentol in infants with Dravet syndrome is safe and beneficial, significantly reducing long-lasting seizures including status epilepticus, hospitalizations, and mortality in the critical first years of life.


Assuntos
Epilepsias Mioclônicas , Estado Epiléptico , Lactente , Masculino , Feminino , Humanos , Pré-Escolar , Anticonvulsivantes/efeitos adversos , Estudos Retrospectivos , Resultado do Tratamento , Epilepsias Mioclônicas/complicações , Epilepsias Mioclônicas/tratamento farmacológico , Convulsões/tratamento farmacológico , Estado Epiléptico/tratamento farmacológico
4.
Epilepsia ; 63(11): 2911-2924, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36054371

RESUMO

OBJECTIVE: Many early-onset epilepsies present as developmental and epileptic encephalopathy associated with refractory seizures, altered psychomotor development, and disorganized interictal cortical activity. Abnormal upregulation of specific N-methyl-d-aspartate receptor (NMDA-R) subunits is being disentangled as one of the mechanisms of severe early-onset epilepsies. In tuberous sclerosis complex (TSC), upregulation of the GluN2C subunit of the NMDA-R with slow deactivation kinetic results in increased neuronal excitation and synchronization. METHODS: Starting from an available GluN2C/D antagonist, NMDA-R-modulating compounds were developed and screened using a patch clamp on neuronal culture to select those with the strongest inhibitory effect on glutamatergic NMDA currents. For these selected compounds, blood pharmacokinetics and passage through the blood-brain barrier were studied. We tested the effect of the most promising compounds on epileptic activity in Tsc1+/- mice brain slices with multielectrode array, and then in vivo at postnatal ages P14-P17, comparable with the usual age at epilepsy onset in human TSC. RESULTS: Using a double-electrode voltage clamp on isolated NMDA currents, we identified the most prominent antagonists of the GluN2C subunit with no effect on GluN2A as a means of preventing side effects. The best compound passing through the blood-brain barrier was selected. Applied in vivo in six Tsc1+/- mice at P14-P17, this compound reduced or completely stopped spontaneous seizures in four of them, and decreased the background activity disorganization. Furthermore, ictal-like discharges stopped on a human brain sample from an infant with epilepsy due to TSC. INTERPRETATION: Subunit-selective inhibition is a valuable target for developing drugs for severe epilepsies resulting from an upregulation of NMDA-R subunit-mediated transmission.


Assuntos
Epilepsia , Esclerose Tuberosa , Animais , Humanos , Lactente , Camundongos , Anticonvulsivantes/farmacologia , Anticonvulsivantes/uso terapêutico , Epilepsia/etiologia , Epilepsia/complicações , N-Metilaspartato , Receptores de N-Metil-D-Aspartato , Convulsões/etiologia , Convulsões/complicações , Esclerose Tuberosa/complicações
5.
Dev Med Child Neurol ; 61(10): 1229-1236, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-30828793

RESUMO

AIM: To assess the relevance and generalizability across countries of concepts of the impact of Dravet syndrome beyond seizures, as recognized by families. METHOD: Caregivers of children with Dravet syndrome in four countries (Australia [n=8]; USA, UK, and Italy [all n=4]) participated in 1-hour qualitative telephone interviews, identifying key Dravet syndrome concepts. Interviews were recorded, transcribed, and, where necessary, translated into English for thematic analysis. Conceptual saturation was assessed and findings compared to the previously developed French conceptual disease model. RESULTS: The most common seizure types reported by caregivers were tonic-clonic, absence, or focal-impaired awareness (localized/partial). Fever and physical activity were the most commonly reported triggers. Patient-relevant impacts included impairment in cognition, motor skills, communication, social skills, and behavioural functioning. Caregivers consistently reported negative social, physical, and family impacts. Concepts identified in the interviews showed similarity with the French conceptual model. Minor differences between countries are likely to reflect variations in health care systems. INTERPRETATION: Findings in Italy, Australia, UK, and USA confirm that the key impacts of Dravet syndrome on children and caregivers identified in France are generalizable across countries. Key symptom and impact concepts relevant to children and parents should be targeted as critical outcomes in new therapy evaluations. WHAT THIS PAPER ADDS: Relevance of the impact of Dravet syndrome on children and caregivers was confirmed across countries. Patient and caregiver-relevant Dravet syndrome impacts contribute to poorer health-related quality of life. Indirect seizure impacts were reported to be as important as direct impacts. Country-specific differences in concepts probably reflect differences in health care systems.


PERCEPCIÓN DEL IMPACTO DEL SÍNDROME DE DRAVET EN NIÑOS Y CUIDADORES EN MÚLTIPLES PAÍSES: UNA OBSERVACIÓN MÁS ALLÁ DE LAS CONVULSIONES: OBJETIVO: Evaluar la relevancia y la generalización de los conceptos del impacto del síndrome de Dravet, más allá de las convulsiones, en distintos países y como lo reconocen las familias. METODO: Cuidadores de niños con síndrome de Dravet en cuatro países (Australia [n=8], EEUU, Reino Unido e Italia [todos n=4]) participaron de una entrevista cualitativa de una hora de duración, identificando conceptos claves en el síndrome de Dravet. Las entrevistas fueron grabadas, transcriptas, y si era necesario, traducidas al inglés para análisis temáticos. Se evaluó la saturación conceptual y los resultados se compararon con el modelo conceptual de enfermedad francés, desarrollado previamente. RESULTADOS: Los tipos más comunes de convulsión reportados por los cuidadores fueron la tónico-clónica, las ausencias o las focales con alteración de la conciencia (localizadas/parciales). La fiebre y las actividades físicas fueron los desencadenantes más comúnmente reportados. Los impactos reportados en los pacientes fueron alteraciones en la cognición, habilidades motrices, comunicación, habilidades sociales y funcionamiento conductual. Los cuidadores informaron sistemáticamente sobre los impactos negativos a nivel social, físico y familiar. Los conceptos identificados en las entrevistas mostraron similitud con el modelo conceptual francés. Es probable que las diferencias menores entre países reflejen variaciones en los sistemas de atención de salud. INTERPRETACIÓN: Los hallazgos en Italia, Australia, Reino Unido y EEUU confirman que las alteraciones claves del síndrome de Dravet en niños y cuidadores identificados en Francia son generalizables en todos los países. Los síntomas claves y las alteraciones relevantes para los niños y los padres deben ser considerados como objetivos críticos de evolución cuando se evalúan el diseño de nuevas terapias.


PERCEPÇÃO DO IMPACTO DA SÍNDROME DE DRAVET EM CRIANÇAS E CUIDADORES EM MÚLTIPLOS PAÍSES: OLHANDO PARA ALÉM DAS CONVULSÕES: OBJETIVO: Avaliar a relevância e generalizabilidade entre países dos conceitos sobre o impacto da síndrome de Dravet para além das convulsões, com base no reconhecimento das famílias. MÉTODO: Cuidadores de crianças com síndrome de Dravet em quatro países (Australia [n=8]; EUA, Reino Unido, e Itália [all n=4]) participaram de entrevistas qualitativas por telefone com duração de 1 hora, identificando conceitos chave da síndrome de Dravet. As entrevistas foram gravadas, transcritas, e quando necessário, traduzidas para o inglês para análise temática. A saturação conceitual foi avaliada e os resultados comparados com o modelo conceitual francês da doença desenvolvido previamente. RESULTADOS: Os tipos mais comuns de convulsões reportados pelos cuidadores eram tônico-clônico, ausência, ou redução focal da consciência (localizada/parcial). Febre e atividade física foram os gatilhos mais comumente reportados. Os impactos relevantes para os pacientes incluíram deficiências na cognição, habilidades motoras, comunicação, habilidades sociais, e funcionamento comportamental. Os cuidadores reportaram impactos negativos sociais, físicos e familares. Os conceitos identificados nas entrevistas mostraram similaridades com o modelo conceitural francês. Diferenças pequenas entre países provavelmente refletem variações nos sistemas de cuidado à saúde. INTERPRETAÇÃO: Achados na Itália, Austrália, Reino unido e EUA confirmam que os impactos principais da síndrome de Dravet em crianças e cuidadores identificados na Franca são generalizáveis entre países. Os principais sintomas e conceitos de impacto relevantes para crianças e pais devem ser visados como desfechos críticos na avaliação de novas terapias.


Assuntos
Cuidadores/psicologia , Epilepsias Mioclônicas/psicologia , Adolescente , Adulto , Austrália , Criança , Pré-Escolar , Comparação Transcultural , Epilepsias Mioclônicas/complicações , Feminino , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Relações Pais-Filho , Pesquisa Qualitativa , Qualidade de Vida , Reino Unido , Estados Unidos
6.
Eur J Nucl Med Mol Imaging ; 45(8): 1449-1460, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29594410

RESUMO

PURPOSE: To assess the localizing value of 18F-FDG PET in patients operated on for drug-resistant epilepsy due to focal cortical dysplasia type 2 (FCD2). METHODS: We analysed 18F-FDG PET scans from 103 consecutive patients (52 males, 7-65 years old) with histologically proven FCD2. PET and MRI data were first reviewed by visual analysis blinded to clinical information and FCD2 location. The additional value of electroclinical data and PET/MRI coregistration was assessed by comparison with pathological results and surgical outcomes. RESULTS: Visual analysis of PET scans showed focal or regional hypometabolism corresponding to the FCD2 in 45 patients (44%), but the findings were doubtful or misleading in 37 patients and negative in 21. When considering electroclinical data, positive localization was obtained in 73 patients, and this increased to 85 (83%) after coregistration of PET and MRI data. Under the same conditions, MRI was positive in 61 patients (59%), doubtful in 15 and negative in 27. The additional value of PET was predominant in patients negative or doubtful on MRI, localizing the FCD2 in 35 patients (83%). Interobserver agreement correlated with the grade of hypometabolism: it was good in patients with mild to severe hypometabolism (82-95%), but moderate in those with subtle/doubtful hypometabolism (45%). The main factors influencing positive PET localization were the grade of hypometabolism and the size of the FCD2 (P < 0.0001). Misleading location (nine patients) was associated with a small FCD2 in the mesial frontal and central regions. Following limited cortical resection mainly located in extratemporal areas (mean follow-up 5.6 years), a seizure-free outcome was achieved in 94% of patients, including Engel's class IA in 72%. CONCLUSION: In this series, 18F-FDG PET contributed to the localization of FCD2 in 83% of patients. This high localizing value was obtained by integration of electroclinical data and PET/MRI coregistration. This approach may help improve the surgical outcome in extratemporal epilepsy, even in patients negative on MRI.


Assuntos
Eletroencefalografia , Epilepsia/diagnóstico por imagem , Malformações do Desenvolvimento Cortical/diagnóstico por imagem , Tomografia por Emissão de Pósitrons , Adolescente , Adulto , Idoso , Criança , Feminino , Fluordesoxiglucose F18 , França , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Adulto Jovem
7.
Eur J Nucl Med Mol Imaging ; 45(8): 1465, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29704039

RESUMO

The original version of this article has added numbers in the text which are unnecessary. Correct line should be: "We also performed PET/MRI based surgical resections in an increasing number of MRI negative/ doubtful cases with favourable outcome."

8.
Epilepsia ; 59(9): 1705-1717, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30132836

RESUMO

OBJECTIVE: To evaluate continuing stiripentol treatment in adulthood in Dravet syndrome (DS). METHOD: Longitudinal data were collected from the last visit prior to age 15 years (V15 y ) to the last visit in adulthood (Vadult ) in the 40 DS patients (32 typical, eight atypical) of a French historical cohort (Paris) of subjects who continued stiripentol from childhood or adolescence to adulthood. RESULTS: At Vadult (18-40 years, median = 23 years), all the patients were still receiving stiripentol (exposure = 3-24 years, median = 18 years), associated with clobazam (40/40), valproate (39/40), and topiramate (21/40). Between V15 y and Vadult , stiripentol was interrupted in five patients (two for adverse events) but reintroduced following seizure aggravation. Loss of appetite affected 15 of 40 patients but resolved after reducing the dose of stiripentol or valproate; no other new stiripentol-related adverse events were reported. Mean stiripentol dose was progressively decreased from 39 to 25 mg/kg/d (P = 0.0002), whereas clobazam (0.27 mg/kg/d) and valproate (14 mg/kg/d) remained stable. At Vadult , 37 of 40 patients still had generalized tonic-clonic seizures, but none still had status epilepticus (vs three at V15 y ) and only one had myoclonia. During adulthood, generalized tonic-clonic seizure frequency and duration continued to decrease (P = 0.02, P = 0.008) and 10 patients experienced seizure-free periods ≥ 1 years (up to 5 years). All patients already had intellectual disability at V15 y , but retardation was more severe at Vadult (P = 0.03). Furthermore, neurological/gait condition had declined (two patients became bedridden) and behavior had worsened (P < 0.0002). Nevertheless, the 33 patients on stiripentol from infancy/childhood (<15 years) tended to have better seizure outcome in midadulthood than the seven treated from adolescence (>15 years) and the DS patients treated from adult age or stiripentol-naive subjects reported in the literature. SIGNIFICANCE: The efficacy and safety of the stiripentol/valproate/clobazam combination started at pediatric age are maintained at very long term during adulthood. Such prolonged stiripentol therapy tends to positively impact the late prognosis of epilepsy, especially when initiated before adolescence.


Assuntos
Anticonvulsivantes/uso terapêutico , Dioxolanos/uso terapêutico , Epilepsias Mioclônicas/tratamento farmacológico , Resultado do Tratamento , Adolescente , Adulto , Criança , Progressão da Doença , Quimioterapia Combinada , Epilepsias Mioclônicas/complicações , Feminino , Humanos , Estudos Longitudinais , Masculino , Adulto Jovem
9.
Epilepsy Behav ; 82: 133-139, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29625363

RESUMO

OBJECTIVES: Little is known about off-label use and manipulations to achieve the prescribed dose of antiepileptic drugs (AEDs) in outpatient prescriptions. This study aimed to evaluate this practice in a tertiary center for child epilepsy. METHODS: We reviewed off-label use and manipulations of AEDs delivered to the outpatient's epilepsy clinic. Multivariate logistic regressions were used to determine the factors associated with off-label and manipulated uses. RESULTS: Five hundred eleven consultations generated 897 AED deliveries (1.75/consultation). Off-label use involved 182 (20.3%) of prescribed AEDs. Factors associated with off-label use were polytherapy and new AEDs while increase of age and nondevelopmental and structural-metabolic etiologies have a protective effect. Among the 1725 doses of AEDs prescribed per day, 33.5% generated manipulations (n=582): 40% inadequate (n=237) and 60% adequate (203 syrups, 112 scored tablets, 30 drops medicine). Polytherapy (p<10-4) and the absence of market authorization significantly favored manipulations whereas the increase in age restricted them. CONCLUSION: Off-label use and manipulations of AEDs remain an important problem in home care of children with epilepsy. This is mainly a concern for the most vulnerable groups, i.e., young patients, patients undergoing polytherapy, and patients with developmental and epileptic encephalopathy (DEE). International initiatives have been launched to improve the availability of labeled and adapted drugs in this population.


Assuntos
Anticonvulsivantes/uso terapêutico , Epilepsia/tratamento farmacológico , Uso Off-Label/estatística & dados numéricos , Adolescente , Adulto , Criança , Pré-Escolar , Estudos Transversais , Epilepsia/epidemiologia , Feminino , Humanos , Lactente , Modelos Logísticos , Masculino , Pacientes Ambulatoriais/estatística & dados numéricos , Estudos Prospectivos , Estados Unidos , Adulto Jovem
10.
Epilepsy Behav ; 78: 232-242, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-29108913

RESUMO

BACKGROUND: Dravet Syndrome (DS) is a rare developmental and epileptic encephalopathy characterized by multiple seizures, frequently prolonged and treatment refractory, with significant developmental disabilities and behavioral and psychiatric disorders. Patients with DS require intensive support and supervision from a caregiver, impacting significantly on both patients' and caregivers' lives. This study aimed to identify core concepts to measure the impact on both patients and caregivers in future DS clinical trials. METHODS: Qualitative concept elicitation interviews were conducted with caregivers and healthcare professionals involved in caring for children with DS (aged 2-18years) in France to identify important concepts related to the global impact of DS. Interviews explored a range of concepts, including triggers, symptoms, impacts, and coping strategies, from which a conceptual model was developed. A Delphi consensus panel with eight international clinical experts aimed to identify important and relevant endpoints. RESULTS: Seizure was the most commonly reported symptom with DS further impacting children's cognitive and behavioral functioning. Caregivers identified impact concepts not reported by healthcare professionals. Both groups described additional impacts on wider family members and home modifications. Clinical experts agreed on the inclusion of five patient- and caregiver-relevant concepts for measurement in future DS clinical trials in a composite endpoint. The five concepts for inclusion were; seizures, expressive communication of the child, receptive communication of the child, impact on daily activities, and social functioning of the caregiver. CONCLUSIONS: This study showed the wider potential impact of DS to extend beyond that of seizures, demonstrating that there is a need for additional patient- and caregiver-relevant concepts to be measured in clinical trials to fully identify the value of therapeutic interventions.


Assuntos
Cuidadores/psicologia , Epilepsias Mioclônicas/terapia , Avaliação de Resultados em Cuidados de Saúde/métodos , Adaptação Psicológica , Adolescente , Adulto , Atitude do Pessoal de Saúde , Criança , Pré-Escolar , Comunicação , Formação de Conceito , Deficiências do Desenvolvimento/psicologia , Epilepsias Mioclônicas/psicologia , Síndromes Epilépticas , Família/psicologia , Feminino , França , Humanos , Masculino , Pessoa de Meia-Idade , Relações Pais-Filho , Convulsões/psicologia , Espasmos Infantis
11.
Eur J Clin Pharmacol ; 74(6): 793-803, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29564480

RESUMO

PURPOSE: The objective of this work was to develop a population pharmacokinetic model for a prolonged-release granule formulation of valproic acid (VPA) in children with epilepsy and to determine the doses providing a VPA trough concentration (Ctrough) within the target range (50-100 mg/L). METHODS: Ninety-eight children (1-17.6 years, 325 plasma samples) were included in the study. The model was built with NONMEM 7.3. The probability to obtain Ctrough between 50 and 100 mg/L was determined by the Monte Carlo simulations for doses of 20, 30, 40, and 60 mg/kg/day and body weights between 10 and 70 kg. RESULTS: A one compartment model, with first-order absorption and flip-flop parameterization and linear elimination, but taking protein binding into account, was used to describe the data. Typical values for unbound VPA clearance and distribution volume were 6.24 L/h/70 kg and 130 L/h/70 kg respectively. Both parameters were related to body weight via allometric models. The highest probability to obtain a Ctrough within the target range for 10-kg children was obtained with a 40 mg/kg daily dose, whereas daily doses of 30 and 20 mg/kg were found appropriate for 20 to 30- and ≥ 40-kg children respectively. However, for these same doses, the exposure to unbound VPA could differ by 40%. CONCLUSIONS: If the present study supports the current dose recommendations of 20-30 mg/kg/day, except for children under 20 kg, who may need higher doses, it also highlights the need for further research on the pharmacokinetics/pharmacodynamic profile of unbound VPA.


Assuntos
Anticonvulsivantes/farmacocinética , Epilepsia/metabolismo , Modelos Biológicos , Ácido Valproico/farmacocinética , Adolescente , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/sangue , Peso Corporal , Criança , Pré-Escolar , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/farmacocinética , Epilepsia/sangue , Feminino , Humanos , Lactente , Masculino , Método de Monte Carlo , Ligação Proteica , Ácido Valproico/administração & dosagem , Ácido Valproico/sangue
12.
Br J Clin Pharmacol ; 83(12): 2695-2708, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-28771787

RESUMO

AIMS: Oxcarbazepine is an antiepileptic drug with an activity mostly due to its monohydroxy derivative metabolite (MHD). A parent-metabolite population pharmacokinetic model in children was developed to evaluate the consistency between the recommended paediatric doses and the reference range for trough concentration (Ctrough ) of MHD (3-35 mg l-1 ). METHODS: A total of 279 plasma samples were obtained from 31 epileptic children (age 2-12 years) after a single dose of oxcarbazepine. Concentration-time data were analysed with Monolix 4.3.2. The probability to obtain Ctrough between 3-35 mg l-1 was determined by Monte Carlo simulations for doses ranging from 10 to 90 mg kg-1  day-1 . RESULTS: A parent-metabolite model with two compartments for oxcarbazepine and one compartment for MHD best described the data. Typical values for oxcarbazepine clearance, central and peripheral distribution volume and distribution clearance were 140 l h-1  70 kg-1 , 337 l 70 kg-1 , 60.7 l and 62.5 l h-1 , respectively. Typical values for MHD clearance and distribution volume were 4.11 l h-1  70 kg-1 and 54.8 l 70 kg-1 respectively. Clearances and distribution volumes of oxcarbazepine and MHD were related to body weight via empirical allometric models. Enzyme-inducing antiepileptic drugs (EIAEDs) increased MHD clearance by 29.3%. Fifty-kg children without EIAEDs may need 20-30 mg kg-1  day-1 instead of the recommended target maintenance dose (30-45 mg kg-1  day-1 ) to obtain Ctrough within the reference range. By contrast, 10-kg children with EIAEDs would need 90 mg kg-1  day-1 instead of the maximum recommended dose of 60 mg kg-1  day-1 . CONCLUSION: This population pharmacokinetic model of oxcarbazepine supports current dose recommendations, except for 10-kg children with concomitant EIAEDs and 50-kg children without EIAEDs.


Assuntos
Anticonvulsivantes/farmacocinética , Carbamazepina/análogos & derivados , Epilepsia/tratamento farmacológico , Modelos Biológicos , Fatores Etários , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/sangue , Área Sob a Curva , Biotransformação , Carbamazepina/administração & dosagem , Carbamazepina/sangue , Carbamazepina/farmacocinética , Criança , Pré-Escolar , Simulação por Computador , Epilepsia/sangue , Epilepsia/diagnóstico , Feminino , Humanos , Hidroxilação , Masculino , Método de Monte Carlo , Oxcarbazepina
13.
Epilepsy Behav ; 74: 33-40, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28683344

RESUMO

OBJECTIVES: To describe the semiology and EEG characteristics of the age-related pattern of sleep/nocturnal (S/N) seizures in patients with Dravet Syndrome (DS). METHODS: We retrospectively analysed the clinical and EEG data of DS patients followed at our reference centre for Rare Epilepsies. We included patients aged two years and older who fulfilled clinical and EEG criteria of DS (ILAE 1989). Genetic testing for SCN1A was done in all, followed by PCDH19 if this was negative. Patients showing a genetic abnormality in PCDH19 were excluded. Of 73 DS patients followed at our centre, 26 (15 males and 11 females), called the S/N group, experienced a switch in the circadian rhythm of seizures, from mainly awake/diurnal to mainly S/N seizures. We retrospectively analysed their clinical, EEG and genetic data. We have compared them to a second group of 7 patients (4 males and 3 females), aged more than 11years, the non-S/N group, who did not develop S/N seizures. RESULTS: We observed a pattern of S/N seizures concomitant with a decrease of awake seizures between 4 and 11years (median 6years 6months). S/N seizures were brief but often occurred in clusters of 2-15 per night. Seizures were mostly focal (26) with frontal-central onset (25) and tonic or tonic-vibratory in semiology. S/N seizure clusters were difficult to control despite many AEDs trials. Benzodiazepines reduced seizure recurrence within a cluster in some patients. While no significant differences were found between groups regarding clinical features, the presence of frontal and central anomalies on wake and sleep EEG was significantly associated with the presence of the S/N pattern. CONCLUSIONS: Patients with DS often develop a characteristic clinical and EEG pattern with S/N tonic and tonic clonic seizures that is often underdiagnosed. Seizure semiology and EEG pattern differ from LGS but may worsen the quality of sleep of such patients and their families. The possible role of this pattern in SUDEP occurring mainly during sleep and at the same age should be further explored. Current AEDs have limited efficacy and specific drug trials should be proposed.


Assuntos
Epilepsias Mioclônicas/diagnóstico , Epilepsias Mioclônicas/genética , Convulsões/diagnóstico , Convulsões/genética , Sono/fisiologia , Fatores Etários , Criança , Pré-Escolar , Ritmo Circadiano/fisiologia , Eletroencefalografia/tendências , Epilepsias Mioclônicas/fisiopatologia , Feminino , Humanos , Masculino , Estudos Retrospectivos , Convulsões/fisiopatologia
14.
Epilepsy Behav ; 69: 86-94, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28236728

RESUMO

The neural networks involved in language recovery following hemispherotomy of the dominant hemisphere after language acquisition in children remain poorly known. Twelve hemispherotomized children (mean age at surgery: 11.3years) with comparable post-operative neuropsychological patterns underwent multi-task language functional MRI. Three of them had recovered from an initial postoperative aphasia i.e., hemispherotomy was performed on the language-dominant hemisphere. Our main results revealed (1) perisylvian activations in all patients after either left or right hemispherotomy; (2) no differences in activations between groups regarding the side of hemispherotomy; (3) additional activations in pre-frontal (3/3) and hippocampal/parahippocampal and occipito-parietal (2/3) areas, when comparing language activation in each of the three subjects with hemispherotomy of the language-dominant hemisphere to the group of 9 non-dominant hemispherotomized patients. These neural networks support the stronger engagement of learning and memory during language recovery in a hemisphere that was not initially actively subserving language.


Assuntos
Encéfalo/fisiologia , Lateralidade Funcional/fisiologia , Hemisferectomia/tendências , Idioma , Rede Nervosa/fisiologia , Plasticidade Neuronal/fisiologia , Adolescente , Encéfalo/diagnóstico por imagem , Encéfalo/cirurgia , Mapeamento Encefálico/métodos , Criança , Feminino , Seguimentos , Humanos , Transtornos da Linguagem/diagnóstico por imagem , Transtornos da Linguagem/fisiopatologia , Testes de Linguagem , Imageamento por Ressonância Magnética/métodos , Masculino , Rede Nervosa/diagnóstico por imagem , Rede Nervosa/cirurgia , Recuperação de Função Fisiológica/fisiologia , Adulto Jovem
15.
Epilepsy Behav ; 69: 153-160, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28188045

RESUMO

This is the third of three papers that summarize the second symposium on Transition in Epilepsies held in Paris in June 2016. This paper focuses on treatment issues that arise during the course of childhood epilepsy and make the process of transition to adult care more complicated. Some AEDs used during childhood, such as stiripentol, vigabatrin, and cannabidiol, are unfamiliar to adult epilepsy specialists. In addition, new drugs are being developed for treatment of specific childhood onset epilepsy syndromes and have no indication yet for adults. The ketogenic diet may be effective during childhood but is difficult to continue in adult care. Regional adult epilepsy diet clinics could be helpful. Polytherapy is common for patients transitioning to adult care. Although these complex AED regimes are difficult, they are often possible to simplify. AEDs used in childhood may need to be reconsidered in adulthood. Rescue medications to stop prolonged seizures and clusters of seizures are in wide home use in children and can be continued in adulthood. Adherence/compliance is notoriously difficult for adolescents, but there are simple clinical approaches that should be helpful. Mental health issues including depression and anxiety are not always diagnosed and treated in children and young adults even though effective treatments are available. Attention deficit hyperactivity disorder and aggressive behavior disorders may interfere with transition and successful adulthood but these can be treated. For the majority, the adult social outcome of children with epilepsy is unsatisfactory with few proven interventions. The interface between pediatric and adult care for children with epilepsy is becoming increasingly complicated with a need for more comprehensive transition programs and adult epileptologists who are knowledgeable about special treatments that benefit this group of patients.


Assuntos
Congressos como Assunto , Dieta Cetogênica/tendências , Epilepsia/terapia , Transição para Assistência do Adulto/tendências , Adolescente , Adulto , Fatores Etários , Anticonvulsivantes/uso terapêutico , Canabidiol/uso terapêutico , Criança , Dieta Cetogênica/métodos , Dioxolanos/uso terapêutico , Epilepsia/diagnóstico , Epilepsia/epidemiologia , Epilepsia/psicologia , Humanos , Resultado do Tratamento , Vigabatrina/uso terapêutico , Adulto Jovem
16.
Hum Brain Mapp ; 37(8): 3017-30, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27133021

RESUMO

The aim of this study was to investigate the age-related changes in resting-state neurometabolic connectivity from childhood to adulthood (6-50 years old). Fifty-four healthy adult subjects and twenty-three pseudo-healthy children underwent [(18) F]-fluorodeoxyglucose positron emission tomography at rest. Using statistical parametric mapping (SPM8), age and age squared were first used as covariate of interest to identify linear and non-linear age effects on the regional distribution of glucose metabolism throughout the brain. Then, by selecting voxels of interest (VOI) within the regions showing significant age-related metabolic changes, a psychophysiological interaction (PPI) analysis was used to search for age-induced changes in the contribution of VOIs to the metabolic activity in other brain areas. Significant linear or non-linear age-related changes in regional glucose metabolism were found in prefrontal cortices (DMPFC/ACC), cerebellar lobules, and thalamo-hippocampal areas bilaterally. Decreases were found in the contribution of thalamic, hippocampal, and cerebellar regions to DMPFC/ACC metabolic activity as well as in the contribution of hippocampi to preSMA and right IFG metabolic activities. Increases were found in the contribution of the right hippocampus to insular cortex and of the cerebellar lobule IX to superior parietal cortex metabolic activities. This study evidences significant linear or non-linear age-related changes in regional glucose metabolism of mesial prefrontal, thalamic, mesiotemporal, and cerebellar areas, associated with significant modifications in neurometabolic connectivity involving fronto-thalamic, fronto-hippocampal, and fronto-cerebellar networks. These changes in functional brain integration likely represent a metabolic correlate of age-dependent effects on sensory, motor, and high-level cognitive functional networks. Hum Brain Mapp 37:3017-3030, 2016. © 2016 Wiley Periodicals, Inc.


Assuntos
Envelhecimento/metabolismo , Encéfalo/crescimento & desenvolvimento , Encéfalo/metabolismo , Glucose/metabolismo , Vias Neurais/crescimento & desenvolvimento , Vias Neurais/metabolismo , Adolescente , Adulto , Mapeamento Encefálico , Criança , Feminino , Fluordesoxiglucose F18 , Humanos , Masculino , Pessoa de Meia-Idade , Tomografia por Emissão de Pósitrons , Compostos Radiofarmacêuticos , Adulto Jovem
17.
Epilepsia ; 57(4): 648-59, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26873267

RESUMO

OBJECTIVE: To describe the epileptic phenotype of Tsc1(+/-) mice pups in comparison with age-related seizures in human tuberous sclerosis complex (TSC). METHODS: Tsc1(+/-) and control mice underwent intracranial electroencephalography (EEG) recording at postnatal ages (P)8 to P33, with linear silicon probe implanted in the somatosensory cortex of one or both hemispheres for 8-24 h. Ictal events were classified visually by independent analyzers; distinct EEG patterns were related to age and analyzed to quantify field potential characteristics and signal dynamics between hemispheres. We collected retrospectively 20 infants with prenatally diagnosed TSC and EEG before seizure onset, and analyzed the electroclinical course of epilepsy, taking into account a first-line treatment by vigabatrin. RESULTS: Spontaneous seizures were disclosed in 55% of Tsc1(+/-) mice at P9-18. Three ictal patterns were identified: from P9 to P12 "spike clusters" consisted of recurring large spikes without clinical correlate; "spasm-like" discharges dominated from P13 to P16 consisting of high amplitude large field potential superimposed with or followed by fast activity repeated every 2-10 s for at least 20 s, accompanied by rhythmic limb contractions; from P14 to P18 a "tonic-clonic like" pattern comprised rhythmic spikes of increasing amplitude with tonic-clonic movements. Early onset "spike clusters" were mainly unilateral, whereas "spasm-like" and "tonic-clonic like" patterns were bilateral. Interhemispheric propagation was significantly faster for "tonic-clonic like" than for "spasm-like" events. In infants diagnosed prenatally with TSC, clusters of sharp waves or spikes preceded the first seizure, and vigabatrin prevented the development of seizures. Patients treated after seizure onset developed spasms or focal seizures that were pharmacoresistant in 66.7% of cases. SIGNIFICANCE: Tsc1(+/-) mice pups exhibit an age-dependent seizure pattern sequence mimicking early human TSC epilepsy features. Spike clusters before seizure onset in TSC should be considered as a first stage of epilepsy reinforcing the concept of preventive antiepileptic therapy.


Assuntos
Epilepsia/metabolismo , Esclerose Tuberosa/metabolismo , Proteínas Supressoras de Tumor/biossíntese , Adolescente , Fatores Etários , Animais , Criança , Pré-Escolar , Epilepsia/genética , Epilepsia/patologia , Feminino , Seguimentos , Regulação da Expressão Gênica , Humanos , Lactente , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Estudos Retrospectivos , Esclerose Tuberosa/genética , Esclerose Tuberosa/patologia , Proteína 1 do Complexo Esclerose Tuberosa , Proteínas Supressoras de Tumor/genética
18.
Epilepsy Behav ; 48: 61-5, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26057351

RESUMO

Hormonal therapy or ketogenic diet often permits overcoming the challenging periods of many epileptic encephalopathies (West and Lennox-Gastaut syndromes and encephalopathy with continuous spike-waves in slow sleep), but relapse affects over 20% of patients. We report here a monocenter pilot series of 42 consecutive patients in whom we combined oral steroids with the ketogenic diet for corticosteroid-resistant or -dependent epileptic encephalopathy. We retrospectively evaluated the effect on seizure frequency, interictal spike activity, neuropsychological course, and steroid treatment course. Twenty-three patients had West syndrome (WS), 13 had encephalopathy with continuous spike-waves in slow sleep (CSWS), and six others had miscellaneous epileptic encephalopathies. All patients succeeded to reach 0.8 to 1.6g/l ketone bodies in the urine following the usual KD regimen. For at least 6 months, 14/42 responded to the addition of the ketogenic diet: 4/23 with WS, 8/13 with CSWS, and 2/6 with miscellaneous epileptic encephalopathies. The addition of the KD allowed withdrawing steroids in all responders. Among them, 10/15 had been patients with steroid-dependent epileptic encephalopathy and 4/27 patients with steroid-resistant epileptic encephalopathy. Therefore, the ketogenic diet can be used successfully in combination with corticosteroids for epileptic encephalopathies. Patients presenting with steroid-dependent CSWS seem to be the best candidates.


Assuntos
Corticosteroides/uso terapêutico , Dieta Cetogênica , Epilepsia/dietoterapia , Epilepsia/tratamento farmacológico , Convulsões/tratamento farmacológico , Corticosteroides/farmacologia , Anticonvulsivantes/uso terapêutico , Eletroencefalografia/efeitos dos fármacos , Feminino , Humanos , Lactente , Síndrome de Lennox-Gastaut/tratamento farmacológico , Masculino , Estudos Retrospectivos , Convulsões/diagnóstico , Sono/efeitos dos fármacos , Espasmos Infantis/diagnóstico , Espasmos Infantis/tratamento farmacológico , Resultado do Tratamento
19.
Epilepsy Behav ; 44: 86-9, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25659044

RESUMO

While the current literature on children suffering from temporal lobe epilepsy (CTLE) mostly focuses on material-related episodic memory deficits according to seizure-onset lateralization, the present study examined associative episodic memory according to the type of information to memorize (e.g., factual, spatial, and sequential) and further investigated subjective and objective recollection. Eleven children with left temporal lobe epilepsy (LTLE), 10 children with right temporal lobe epilepsy (RTLE), among whom 9 displayed hippocampal sclerosis (HS), and 42 healthy controls completed the WHAT-WHEN-WHERE protocol (Guillery-Girard et al., 2013). Group comparisons were first conducted according to the affected side and second according to the underlying pathology. Results showed associative memory impairments in patients irrespective of the affected side. Moreover, this study revealed that HS is particularly deleterious to associative and subjective recollection in CTLE. In addition, this study emphasizes the need for assessing episodic memory in childhood TLE beyond material specificity.


Assuntos
Aprendizagem por Associação/fisiologia , Epilepsia do Lobo Temporal/fisiopatologia , Hipocampo/patologia , Transtornos da Memória/fisiopatologia , Memória Episódica , Rememoração Mental/fisiologia , Adolescente , Criança , Epilepsia do Lobo Temporal/complicações , Feminino , Lateralidade Funcional , Humanos , Masculino , Transtornos da Memória/etiologia , Esclerose/patologia , Lobo Temporal/patologia
20.
Dev Med Child Neurol ; 57(2): 194-9, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25145506

RESUMO

AIM: The aim of the study was to characterize seizures and epilepsy related to hypoglycaemia. METHOD: We analyzed the files of 170 consecutive patients referred for hypoglycaemia (onset 1h to 4y) caused by inborn errors of metabolism (glycogen storage disease type I, fatty acid ß-oxidation disorders, and hyperinsulinism). RESULTS: Ninety patients (42 males and 48 females; 38 neonates and 52 infants/children) had brief hypoglycaemic seizures (68%) or status epilepticus (32%). Status epilepticus occurred earlier (mean 1.4d) than brief neonatal seizures (4.3d, p=0.02). Recurrent status epilepticus followed initial status epilepticus and was often triggered by fever. Epilepsy developed in 21 patients. In 18 patients, epilepsy followed hypoglycaemic status epilepticus and began with shorter delay when associated with grey matter lesions (1.9mo, standard error of the mean [SEM] 1mo) than with white matter damage (3.3y [SEM 1y], p=0.003). Three patients with hyperinsulinism developed idiopathic epilepsy following brief neonatal seizures. INTERPRETATION: Brief neonatal hyperinsulinaemic hypoglycaemic seizures have characteristics of idiopathic neonatal seizures. Neonatal status epilepticus should be prevented by the systematic measurement of glucose blood level. Recurrent seizures never consist of status epilepticus when following brief initial seizures. Epilepsy is symptomatic of brain damage with shorter delay in the case of grey rather than white matter lesions, except in a few idiopathic cases in which epilepsy and hyperinsulinism may share a common genetic background.


Assuntos
Epilepsia/etiologia , Doença de Depósito de Glicogênio Tipo I/complicações , Hiperinsulinismo/complicações , Hipoglicemia/etiologia , Erros Inatos do Metabolismo/complicações , Convulsões/etiologia , Adolescente , Glicemia , Criança , Pré-Escolar , Progressão da Doença , Epilepsia/epidemiologia , Epilepsia/fisiopatologia , Feminino , Doença de Depósito de Glicogênio Tipo I/epidemiologia , Humanos , Hiperinsulinismo/epidemiologia , Hipoglicemia/epidemiologia , Hipoglicemia/fisiopatologia , Incidência , Lactente , Recém-Nascido , Masculino , Erros Inatos do Metabolismo/epidemiologia , Estudos Retrospectivos , Convulsões/epidemiologia , Convulsões/fisiopatologia , Estado Epiléptico/epidemiologia , Estado Epiléptico/etiologia , Estado Epiléptico/fisiopatologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA